Cusatuzumab [1864871-20-4]

TargetMol Chemicals

Cusatuzumab

9

1864871-20-4

Antibody

Research Use Only

Cusatuzumab

Cusatuzumab, a human alphaCD70 monoclonal antibody, exhibits cytotoxic activity and enhances antibody-dependent cellular cytotoxicity. It reduces leukemia stem cells (LSCs), triggers gene signatures associated with myeloid differentiation and apoptosis, and holds potential for Acute myeloid leukemia (AML) research [1].

3 years

-20°C

12352203